DNA methylation of the promoter region has been described, indicating that LSAMP is epigenetically inactivated in cancer[6,17], and absent or low expression of LSAMP has been reported to be a frequent characteristic of osteosarcomas[6,12-14]. Here, LSAMP is linked to cancer.